Cargando…
Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity
BACKGROUND: Monitoring and treating metastatic progression remains a formidable task due, in part, to an inability to monitor specific differential molecular adaptations that allow the cancer to thrive within different tissue types. Hence, to develop optimal treatment strategies for metastatic disea...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668614/ https://www.ncbi.nlm.nih.gov/pubmed/33196681 http://dx.doi.org/10.1371/journal.pone.0242384 |